Research and Interests
After obtaining a Bachelor’s+Master’s degree in Clinical Psychology, an MD, and a University Specialization in Psychiatry, Dr. Daniel Vigo worked in clinical, research, teaching, and leadership positions across sectors (public hospitals, NGOs, and for-profit organizations). He developed the first Assertive Community Treatment Department in Argentina, a collaboration between Proyecto Suma, King’s College (UK) and Columbia University (US). He obtained his Doctorate at Harvard, where he focused on burden of disease estimation, service improvement, and health systems assessment. He has published peer-reviewed articles, book chapters, and reports on public health, health systems, global mental health, psychiatric epidemiology, psychopharmacology, psychotherapy, and e-mental health. Of note, his contribution to improving the estimation of the disease burden caused by mental illness is among the most impactful papers in the field of mental health in recent years. He is an Assistant Professor at the University of British Columbia, a Lecturer at Harvard Medical School, an Advisor to PAHO and WHO, and Chair of the Health Services Workgroup of the WHO-World Mental Health Surveys Initiative, among other roles in organizations of national and global standing. Dr. Vigo leads several projects in BC, Canada, and globally, including on E-mental health for University Students, Needs-Based Planning for Mental and Substance Use Disorder Services, Care Options for People with Severe Substance Use Disorders at Imminent Risk of Death and Disability, Estimating Coverage and Quality of Care for Mental Disorders, and Estimating the Disease Burden of Mental Disorders.
Harris, M.,(…) Vigo, D., Wojtyniak, B., Zarkov, Z., Ziv, Y., Kessler, R.C. Perceived helpfulness of treatment for major depressive disorder: findings from the WHO World Mental Health Surveys. JAMA Psychiatry. (in press 2020)
Vigo D, Patten SB, Pajer K, Krausz M, Taylor S, Rush B, Raviola G, Saxena S, Thornicroft G, Yatham LN. Mental health of communities during the COVID-19 pandemic. Canadian Journal of Psychiatry. 2020 May 11.
Krausz M, Westenberg JN, Vigo D, Spence RT, Ramsey D. Emergency Response to COVID-19 in Canada: Platform Development and Implementation for eHealth in Crisis Management. JMIR Public Health and Surveillance. 2020 May 12.
Fernández D, Vigo D, (…), Kessler RC, Haro JM. Patterns of care and dropout rates from outpatient mental healthcare in low-, middle- and high-income countries from the World Health Organization’s World Mental Health Survey Initiative. Psychological Medicine. 2020 Apr 28:1-13.
Vigo D, Jones L, Thornicroft G, Atun R. The Burden of Mental Disorders, Neurological Disorders, Substance Use Disorders and Self-Harm in North America: a comparative epidemiology of Canada, the United States, and Mexico. Can J Psychiatry. 2020 Feb;65(2):87-98.
Pinto JV, Saraf G, Frysch C, Vigo D, Keramatian K, Chakrabarty T, Lam RW, Kauer-Sant’Anna M, Yatham LN.. Cannabidiol as a treatment for mood disorders: A systematic review. Can J Psychiatry. 2019 Dec 13: 706743719895195.
Tabi K, Randhawa A, Choi F, Mithani Z, Albers F, Schnieder M, Nikoo M, Vigo D, Demlova R, Krausz M; Mobile Apps for Medication Management: Review and Analysis. JMIR Ment Health. 2019 Sep 11;7(9):e13608
Vigo, D., Patel, V., Becker, A., Bloom, D., Yip, W., Raviola, G., Saxena, S., Kleinman, A.; A Partnership for Transforming Mental Health Globally; Lancet Psychiatry. January 28, 2019
Vigo, D., Kestel, D., Pendakur, K.,Thornicroft, G., Atun, R; Imbalance between disease burden and government spending on mental, neurological, substance use disorders, and self-harm: health system response in the Americas; Lancet Public Health. Published Online November 13, 2018.
Vigo D, Thornicroft G, Atun R. Estimating the True Global Burden of Mental Illness. Lancet Psychiatry. 2016;3: 171-78.